Description of Abdominal and Gluteo-femoral Subcutaneous Adipose Tissue Cell Population in Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-14

Study Completion Date

2012-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare, in healthy women, the adipose tissue composition between abdomen and thigh and then determine whether differences exist independently of the state of obesity.

The findings of this study may help to explain the mechanism contributing to a beneficial role of gluteo-femoral fat contrasting with a deleterious role of abdominal fat on cardiovascular and metabolic dysfunctions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immune Characterization of Subcutaneous Adipose Tissue

NCT02076087

Determine Immune Cell Types in Subcutaneous Adipose Tissue

COMPLETED

Cryolipolysis on Localized Adiposity

NCT03160976

Subcutaneous Fat

UNKNOWN NA

Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis

NCT06869941

Obesity

RECRUITING

Following Lipectomy to Understand Adipose Tissue Re-accumulation

NCT00995631

Menopause Pre-menopause

COMPLETED NA

Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women

NCT01748994

Obesity Metabolic Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adipose Tissue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-menoposal healthy volunteer women aged between 25 to 45 years

Adipose tissue biopsie (2-3g) have been taken by needle biopsy form the abdomen (periumbilical) and gluteo-femoral (upper thigh) levels

Group Type OTHER

Biopsies

Intervention Type PROCEDURE

Abdominal and gluteo-femoral subcutaneous adipose tissue biopsies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biopsies

Abdominal and gluteo-femoral subcutaneous adipose tissue biopsies

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women between 15 and 45 years old
* with genital activity
* stable weight during the previous 3 months
* BMI from 20 to 28
* regular menstrual cycles (28 +/- 2 days) during the previous 3 months
* reliable means of contraception (systemic hormonal contraception, intrauterine contraceptive device, tubal ligation)
* using the same way of contraception during the previous 3 months
* normal clinical examination
* able to be compliant with the schedule of protocol assessments
* willing and able to provide written informed consent
* affiliated to a National Health Service
* agreeing to being registered on the national file for subjects participating in biomedical research

Exclusion Criteria

* Exclusions related to significant medical disturbances :
* type I and II diabetes
* early menopause
* serious psychological disorders
* uncontrolled thyroid disorders
* know allergy to local anesthetics especially Xylocaine
* abnormal laboratory results
* medical history that, in the opinion of the investigator, makes the subject unsuitable for enrollment
* positive test result for HIV, HCV and/or HBV virus
* positive pregnancy test
* Exclusions related to subject lifestyle :
* smoking \> 10 cigarettes per day
* smoking cessation during the previous 3 months
* weight fluctuation (\>3kg) during the previous 3 months
* alcohol abuse
* coffee or tea consumption \> 6 cups per day
* high consumption of drinks comprising xanthine bases (\>0.5 liters/day)
* consumption of drinks (water or herbal teas) \> 2 liters per day
* Exclusions related to previous or concomitant treatments :
* anticoagulant
* neuroleptic or antidepressant
* medication with draining, lipolytic, appetite suppressant and/or slimming effect
* local or systemic corticosteroid therapy on the test areas
* hormonal treatment other than contraception
* diuretic
* local treatment against cellulitis (mesotherapy,phosphatidylcholine injection, mechanical process)
* thighs liposuction \< 2 years
* chronic treatment with anti-inflammatory
* Exclusions related to the subject :
* unwillingness or inability to comply with the requirements of the protocol
* previous participation in a clinical trial within 30 days
* inability to understand and sign the consent due to linguistic or psychic issues
* subject deprived of liberty or under guardianship, tutorship or judicial protection
* female who are currently pregnant or breastfeeding or female considering becoming pregnant while in the study

Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes